Similar to our observations in breast cancer low SOCS2 expression in prostate cancer is associated with an increased incidence of metastasis and SOCS2 mRNA levels decrease during prostate cancer progression [27]. This evidence concerns the gene SOCS2 and prostate carcinoma.